Porphyrins, Quantitative, 24-Hour Urine
| Porphyrins, Quantitative, 24-Hour Urine | | | |
| Number | | 003194 |
| CPT | | 84120 |
| Related Information | | Porphyrins, Quantitative, Random Urine Urine Testing: Preservative Quick Reference Chart |
| Synonyms | | Coproporphyrin ; Uroporphyrin |
| Test Includes | | Coproporphyrins I and III; uroporphyrins; heptacarboxylporphyrins; hexacarboxylporphyrins; pentacarboxylporphyrins |
| Special Instructions | | The request form must state 24-hour collection volume. |
| Specimen | | Urine (24-hour), protected from light |
Volume | | 2 mL aliquot |
Minimum Volume | | 1.5 mL aliquot |
Container | | Amber plastic urine container with 5 g/L sodium carbonate
(Na2CO3) as the preferred
preservative. No preservative is also acceptable. Do
not use acid preservative. Use amber plastic urine
cup and amber-top; order LabCorp No 20656. (If
amber cups are unavailable, cover plastic container
completely, top and bottom, with aluminum foil. Identify
specimen with patient name directly on the container
and on the outside of the aluminum foil. Secure with
tape.) |
| Collection | | Instruct patient to void at 8 AM (or 8 PM) and discard the specimen. Then collect all the urine including the final specimen voided at the end of the 24-hour collection period (ie, 8 AM (or 8 PM) the following day). Specimen must be kept refrigerated during collection. Label container with patient's name, and date and time collection started and finished. Measure and record total urine volume. Mix well; send aliquot to laboratory. |
| Storage Instructions | | Refrigerate. Do not expose to light. |
| Causes for Rejection | | Stored specimen not refrigerated; specimen exposed to light; acid preservative; pH <3 |
| Reference Interval | | - Coproporphyrin I: 0-24 μg/24 hours
- Coproporphyrin III: 0-74 μg/24 hours
- Heptacarboxylporphyrins: 0-4 μg/24 hours
- Hexacarboxylporphyrins: 0-1 μg/24 hours
- Pentacarboxylporphyrins: 0-4 μg/24 hours
- Uroporphyrins: 0-2 μg/24 hours
See table. Pattern of the Different Porphyrias
| Disease | Uro | Hepta | Hexa | Penta | Copro I | Copro III | | Porphyria cutanea tarda | ++ | ++ | + | + | +* | +* | | Acute intermittent porphyria | ++ | + | + | ++ | +* | ++* | | Porphyria variegata | ++ | + | + | ++ | +* | ++* | | Hereditary coproporphyria | + | + | + | ++ | n* | ++* | | Protoporphyria | v | n | n | v | +* | v | | Morbus Gunther | ++ | + | + | + | ++** | | | Porphobilinogen synthase deficiency | + | + | + | ++ | | ++ | | + = increased; ++ = strongly increased; n = normal; v = varies. | | Values from: Doss M, “Porphyrinstoffwechsel,” Lehrbuch der Klinischen Chemie und Pathobiochemie, Greiling H and Gressner AM (Hrsg), 3, Auflage, Schattauer Verlag Stuttgard New York. | | Values maked with * and ** respectively, are derived from: | | *Hindmarsh JT, Oliveras L, and Greenway DC, “Biochemical Differentiation of the Porphyrias,” Clin Biochem, 1999, 32:609-19. | | **Elder GH, Smith SG, and Smyth SJ, “Laboratory Investigation of the Porphyrias,” Clin Biochem, 1990, 27:395-412. | |
| Use | | Evaluate porphyrias, including those involving deficiencies of enzymes which are needed for heme synthesis and chemical porphyrias. In congenital erythropoietic porphyria, elevations of urinary uroporphyrin and coproporphyrin occur, with the former exceeding the latter. In acute intermittent porphyria, porphobilinogen and delta aminolevulinic acid are elevated in acute attacks, and mild increases of urinary uroporphyrin and coproporphyrin may be found. Porphobilinogen is increased in many but not all patients with acute intermittent porphyria in latent periods. Quantitative porphobilinogen is a better test than delta aminolevulinic acid overall for acute intermittent porphyria, but both are used (as well as the Watson-Schwartz test).1 Coproporphyrin and porphobilinogen excretion in urine are markedly increased during acute attacks of hereditary coproporphyria, increase of urinary uroporphyrin may be found, and increased fecal coproporphyrin III is described. In variegate porphyria in acute attacks, results are similar to those of acute intermittent porphyria. Porphobilinogen and ALA are prone to become normal between attacks. Urine coproporphyrin exceeds uroporphyrin excretion during acute attacks. Chemical porphyrias occur. Porphyrinogenic chemicals include certain halogenated hydrocarbons which cause the excretion of increased uroporphyrin. In lead poisoning elevation of delta aminolevulinic acid greater than that of porphobilinogen occurs and porphobilinogen may be normal. Urinary coproporphyrin characteristically is increased. Free erythrocyte protoporphyrin is increased. Toxins such as lead interfere with heme synthesis and cause porphyrinuria. Increased urine excretion of uroporphyrinogen, uroporphyrin, and coproporphyrin occurs in porphyria cutanea tarda. It is found in middle-aged men who like ethanol, young women on oral contraceptives, and in subjects on dialysis. These patients do not excrete increased porphobilinogen, but may have slight elevations of delta aminolevulinic acid. |
| Limitations | | Increased porphobilinogen may occur in patients on oral contraceptives. This test and delta aminolevulinic acid will not detect protoporphyria. Coproporphyrinuria alone lacks specificity and sensitivity for lead testing. Erythrocyte uroporphyrinogen-I-synthase is decreased in latent acute intermittent porphyria, and is needed in patients with possible latent acute intermittent porphyria. Quantitative porphobilinogen is of value in active and in many cases of latent acute intermittent porphyria, but will miss some of the latter when compared to red cell uroporphyrinogen-I-synthase. |
| Methodology | | High-pressure liquid chromatography (HPLC) with fluorometric detection |
| Additional Information | | Increased urine porphyrin excretion may be secondary to other diseases (eg, hepatobiliary diseases), especially coproporphyrin excretion. These are secondary porphyrinurias. They lack increased urinary porphobilinogen or Δ-ALA, with the important exception of lead poisoning.2 The table provides an abbreviated overview of the porphyrias. Porphyrin fractionation of plasma can be done. Increases of urine porphyrins are found with congenital erythropoietic porphyria, acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria cutanea tarda. Porphyrias: Overview
| Disorder | Inheritance | Age of Clinical Onset | Primary Organ Involvement | Useful Tests | Primary Symptoms | | Congenital erythropoietic porphyria | Autosomal recessive | Birth – 5 y | Erythroid cells | Urinary porphyrins Fecal porphyrins Uroporphyrinogen III synthase, erythrocytes | Severe photosensitivity | | (Günther disease) | Rare | | | Fluorescence of a diaper under Wood light | Red urine Stains diapers Hemolytic anemia | | Acute intermittent porphyria | Autosomal dominant | Adults | Hepatic, probably erythroid cells | Urine porphobilinogen Porphobilinogen deaminase, erythrocyte Urine porphyrins Urinary delta aminolevulinic acid Erythrocyte uroporphyrinogen 1 synthase Fecal porphyrins | Mild / severe neurologic / visceral (autonomic) symptoms | | Precipitating causes include barbiturates, hydantoins, sulfonamides | Most common acute hepatic porphyria in U.S. | | | | Acute attacks | | Hereditary coproporphyria | Autosomal dominant | Adults | Hepatic, possibly erythroid cells | Urine PBG and ALA in acute attacks Urine porphyrins including coproporphyrin Fecal porphyrins Plasma porphyrins | Similar to variegate porphyria Acute attacks | | Variegate porphyria | Autosomal dominant | Adults | Hepatic, possibly erythroid cells | Urine PBG and ALA in acute attacks Urine porphyrins Fecal porphyrins Plasma porphyrins Erythrocyte uroporphyrinogen-1-synthase | Mild / severe photosensitivity, neurologic / visceral symptoms Acute attacks | | Porphyria cutanea tarda | Autosomal dominant, type II (inherited type); sporadic type also known; most common porphyria in U.S. | Adults | Hepatic, possibly erythroid cells; photosensitivity | Urine porphyrins Plasma porphyrins Uroporphyrinogen decarboxylase, type II (RBCs) | Similar to variegate porphyria Photosensitization Liver damage | | Protoporphyria | Autosomal dominant | Usually childhood | Erythroid cells, probably liver | Protoporphyrin, free erythrocyte | Photosensitization Liver damage | | Acquired (intoxication) porphyria | Acquired | Children and adults | Hepatic, erythroid cells | Erythrocyte porphyrins Urinary delta aminolevulinic acid Urine porphobilinogen Urine porphyrins Fecal porphyrins | Mild photosensitivity | Fecal porphyrin examination for hereditary coproporphyria, variegate porphyria, and protoporphyria can be used for adult patients. Stool examination for coproporphyrin and protoporphyrin is recommended for diagnosis of variegate porphyria.3 Neurologic dysfunction occurs in the hepatic porphyrias, the types of porphyria in which acute attacks develop: acute intermittent porphyria, variegate porphyria, hereditary coproporphyria, and ALA dehydrase deficiency. Abdominal pain, caused by autonomic neuropathy, occurs with acute attacks (eg, acute intermittent porphyria). It is the most common symptom of acute intermittent porphyria.2 Cutaneous aspects of the porphyrias are caused by photosensitization (eg, porphyria cutanea tarda, protoporphyria). Hepatic complications are found with porphyria cutanea tarda and protoporphyria. Fluorescence is demonstrable in liver biopsies from patients with the former, as well as siderosis. Crystalline deposits may be found in protoporphyria.2 The amount of porphobilinogen excreted in acute intermittent porphyria is usually greater than the excretion of delta aminolevulinic acid (Δ-ALA). When there is more Δ-ALA, another diagnosis should be considered, including lead poisoning, another type of porphyria, or hereditary tyrosinemia.2 See also Protoporphyrin, Free Erythrocyte, and Zinc Protoporphyrin [010165] , which pertains to lead poisoning, and erythropoietic protoporphyria. The differential diagnosis of lead poisoning is relevant.4 |
| Footnotes | | - Tschudy DP, “Porphyrins,” Chemical Diagnosis and Disease, Brown SS, Mitchell FL, and Young DS, eds, Amsterdam, Holland: Elsevier/North Holland Biomedical Press, 1979, 1039-58.
- Bloomer JR and Bonkovsky HL, “The Porphyrias,” Dis Mon, 1989, 35(1):1-54.
- Muhlbauer JE, Pathak MA, Tishler PV, et al, “Variegate Porphyria in New England,” JAMA, 1982, 247(22):3095-102.
- Bird TD, Wallace DM, and Labbe RF, “The Porphyria, Plumbism, Pottery Puzzle,” JAMA, 1982, 247(6):813-4
|
|